NCT05944380View on ClinicalTrials.gov

PENG Block for Total Hip Arthroplasty

PHASE4CompletedINTERVENTIONAL
Enrollment

556

Participants

Timeline

Start Date

June 16, 2020

Primary Completion Date

June 23, 2022

Study Completion Date

January 30, 2023

Conditions
Hip OsteoarthritisHip ArthropathyHip DiseaseHip Pain Chronic
Interventions
DRUG

Ropivacaine 0.5% Injectable Solution

20 mL 0.5% ropivacaine will be injected for the PENG block

DRUG

0,9% normal saline

20 mL 0.9% normal saline will be injected for the PENG block

Trial Locations (1)

61-701

Poznan Univesity of Medical Sciences, Poznan

All Listed Sponsors
lead

Poznan University of Medical Sciences

OTHER

NCT05944380 - PENG Block for Total Hip Arthroplasty | Biotech Hunter | Biotech Hunter